Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 28: 2429-2433, 1982;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Oost, B. A.
Right arrow Articles by van den Beld, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Oost, B. A.
Right arrow Articles by van den Beld, B.

Clinical Chemistry, Vol 28, 2429-2433, Copyright © 1982 by American Association for Clinical Chemistry

Implications of using different tissue ferritins as antigens for ferritin in serum: four radioimmunoassay kits compared

BA van Oost, FL Willekens, BR van Neerbos and B van den Beld

We compared three serum ferritin radioimmunoassay kits and one noncommercial RIA for ferritin quantitation, with regression analysis of results for sera from 35 ostensibly healthy subjects. There was a good correlation (p less than 0.001) between these various RIAs, but the slope of the regression line varied widely, most probably because of lack of standardization of the serum ferritin assay. Determination of the ferritin content of purified samples of tissue ferritin revealed that the kits differ in specificity, differences for purified human spleen ferritin and human liver ferritin being larger than those for normal sera. Removing the iron from purified liver ferritin increased antiserum binding in two of the kits by twofold, but had no effect in two other kits. We conclude that commercial RIA methods for serum ferritin differ in specificity, and that this difference is related to the source of ferritin used in the production of the antibodies.


The following articles in journals at HighWire Press have cited this article:


Home page
 J. Nutr.Home page
N. Bhandari, S. Taneja, S. Mazumder, R. Bahl, O. Fontaine, M. K. Bhan, and and other members of the Zinc Study Group
Adding Zinc to Supplemental Iron and Folic Acid Does Not Affect Mortality and Severe Morbidity in Young Children
J. Nutr., January 1, 2007; 137(1): 112 - 117.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1982 by the American Association for Clinical Chemistry.